NPR logo

Vioxx and the Business of Drug Testing

  • Download
  • <iframe src="https://www.npr.org/player/embed/4111048/4111049" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Vioxx and the Business of Drug Testing

Vioxx and the Business of Drug Testing

Vioxx and the Business of Drug Testing

  • Download
  • <iframe src="https://www.npr.org/player/embed/4111048/4111049" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Last month, drug company Merck pulled its blockbuster pain reliever Vioxx off the market, citing safety concerns. We take a look at the life of Vioxx and the business of testing drugs.

We no longer support commenting on NPR.org stories, but you can find us every day on Facebook, Twitter, email, and many other platforms. Learn more or contact us.